These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34634166)

  • 1. For consideration by pharmacoepidemiologists.
    Edlavitch SA; Tilson HH
    Pharmacoepidemiol Drug Saf; 2021 Dec; 30(12):1619-1620. PubMed ID: 34634166
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine.
    Issa AM; Carleton B; Gerhard T; Filipski KK; Freedman AN; Kimmel S; Liu G; Longo C; Maitland-van der Zee AH; Sansbury L; Zhou W; Bartlett G
    Pharmacoepidemiol Drug Saf; 2021 Aug; 30(8):985-992. PubMed ID: 33715268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observation and experiment on the cusp of collaboration: a parallel examination of clinical pharmacology and pharmacoepidemiology.
    Lehmann DF
    J Clin Pharmacol; 2000 Sep; 40(9):939-45. PubMed ID: 10975066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interface between pharmacoepidemiology and pharmacogenetics.
    Maitland-van der Zee AH ; de Boer A ; Leufkens HG
    Eur J Pharmacol; 2000 Dec; 410(2-3):121-130. PubMed ID: 11134664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoepidemiology in practice. Current status and future trends.
    Alvarez-Requejo A; Porta M
    Drug Saf; 1995 Jul; 13(1):1-7. PubMed ID: 8527015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes.
    Salvo F; Faillie JL
    Therapie; 2019 Apr; 74(2):255-260. PubMed ID: 30470475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative.
    Paterson JM; Laupacis A; Bassett K; Anderson GM;
    Health Aff (Millwood); 2006; 25(5):1436-43. PubMed ID: 16966744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M; Gill S; Fitzgerald M; Samii A
    J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepidemiology: defining the field and its core content.
    Jones JK; Tilson HH; Lewis JD
    Pharmacoepidemiol Drug Saf; 2012 Jul; 21(7):677-689. PubMed ID: 22488843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curricular considerations for pharmaceutical comparative effectiveness research.
    Murray MD
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):797-804. PubMed ID: 21796716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International data standards for hospital-based drug surveillance.
    Kurata JH; Overhage M; Gabrieli E; Jones JK
    MD Comput; 1995; 12(1):50-7. PubMed ID: 7854080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to ascertain drug safety in the context of benefit. Controversies and concerns.
    Simon LS; Strand CV; Boers M; Brooks PM; Tugwell PS; Bombardier C; Fries JF; Henry D; Goldkind L; Guyatt G; Laupacis A; Lynd L; Macdonald T; Mamdani M; Moore A; Saag KG; Silman AJ; Stevens R; Tyndall A
    J Rheumatol; 2009 Sep; 36(9):2114-21. PubMed ID: 19738223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of associations in pharmacoepidemiology.
    Kaufman DW
    Semin Hematol; 2008 Jul; 45(3):181-8. PubMed ID: 18582625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building a framework for the evaluation of knowledge translation for the Canadian Network for Observational Drug Effect Studies.
    Sketris IS; Carter N; Traynor RL; Watts D; Kelly K;
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1(Suppl 1):8-25. PubMed ID: 30788900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist.
    Radawski C; Morrato E; Hornbuckle K; Bahri P; Smith M; Juhaeri J; Mol P; Levitan B; Huang HY; Coplan P; Li H;
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1233-40. PubMed ID: 26456379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacoepidemiology.
    Jones JK
    Pharmacoepidemiol Drug Saf; 2001; 10(5):457-61. PubMed ID: 11802592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRACE principles: recognizing high-quality observational studies of comparative effectiveness.
    Dreyer NA; Schneeweiss S; McNeil BJ; Berger ML; Walker AM; Ollendorf DA; Gliklich RE;
    Am J Manag Care; 2010 Jun; 16(6):467-71. PubMed ID: 20560690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacoepidemiology: an another kind of drug surveillance].
    Pariente A
    Bull Acad Natl Med; 2015; 199(2-3):275-9. PubMed ID: 27476309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest of pharmacoepidemiology for the study of antibiotic drugs.
    Sommet A
    Therapie; 2019 Apr; 74(2):249-253. PubMed ID: 30678847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting the pharmacoepidemiology literature in obstetrical studies: A guide for clinicians.
    Rasmussen-Torvik LJ; Zumpf KB; Betcher HK; Ciolino JD
    Semin Perinatol; 2020 Apr; 44(3):151225. PubMed ID: 32247516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.